Funck-Brentano C

References (3)

Title : Use of heterologously expressed human cytochrome P450 1A2 to predict tacrine-fluvoxamine drug interaction in man - Becquemont_1998_Pharmacogenet_8_101
Author(s) : Becquemont L , Le Bot MA , Riche C , Funck-Brentano C , Jaillon P , Beaune P
Ref : Pharmacogenetics , 8 :101 , 1998
Abstract : Becquemont_1998_Pharmacogenet_8_101
ESTHER : Becquemont_1998_Pharmacogenet_8_101
PubMedSearch : Becquemont_1998_Pharmacogenet_8_101
PubMedID: 10022747

Title : Glutathione S-transferase theta genetic polymorphism might influence tacrine hepatotoxicity in Alzheimer's patients -
Author(s) : Becquemont L , Lecoeur S , Simon T , Beaune P , Funck-Brentano C , Jaillon P
Ref : Pharmacogenetics , 7 :251 , 1997
PubMedID: 9241666

Title : Influence of the CYP1A2 inhibitor fluvoxamine on tacrine pharmacokinetics in humans - Becquemont_1997_Clin.Pharmacol.Ther_61_619
Author(s) : Becquemont L , Ragueneau I , Le Bot MA , Riche C , Funck-Brentano C , Jaillon P
Ref : Clinical Pharmacology & Therapeutics , 61 :619 , 1997
Abstract : Becquemont_1997_Clin.Pharmacol.Ther_61_619
ESTHER : Becquemont_1997_Clin.Pharmacol.Ther_61_619
PubMedSearch : Becquemont_1997_Clin.Pharmacol.Ther_61_619
PubMedID: 9209244